Lipid Levels After Acute Coronary Syndromes
نویسندگان
چکیده
منابع مشابه
Decreased plasma nociceptin/orphanin FQ levels after acute coronary syndromes.
Foregoing researches made on the N/OFQ system brought up a possible role for this system in cardiovascular regulation. In this study we examined how N/OFQ levels of the blood plasma changed in acute cardiovascular diseases. Three cardiac patient groups were created: enzyme positive acute coronary syndrome (EPACS, n = 10), enzyme negative ACS (ENACS, n = 7) and ischemic heart disease (IHD, n = 1...
متن کاملPrognostic value of C-Reactive Protein in Acute Coronary Syndromes
Introduction: Coronary artery disease (CAD) is among the most common, serious, chronic and life- threatening illnesses in the world. CAD represents a spectrum of conditions, with acute myocardial infarction at one end of it and silent ischemia at the other. There is growing evidence on importance of prognosis of C- reactive protein (CPR) in unstable angina and this protein is a maker of an adve...
متن کاملNon-pharmacological management after acute coronary syndromes
Acute coronary syndromes (ACS) are one of the most common causes of hospitalizations in developed countries. Implementation of optimal treatment in these patients is a significant clinical and social problem. Clinical practice guidelines published by the European Society of Cardiology (ESC) are focused on crucial tasks such as regular physical activity sufficient to increase exercise capacity, ...
متن کاملHigh-dose statins in acute coronary syndromes: not just lipid levels.
FOR MORE THAN A DECADE, STATIN DRUGS HAVE ACCUmulated a remarkable record of successful clinical trials, demonstrating robust evidence for reduction in clinical events, including myocardial infarction, stroke, and cardiovascular death in primary and secondary prevention populations. Recent trials have shown that intensive statin therapy is superior to moderate therapy for reducing morbidity fol...
متن کاملIntensive versus moderate lipid lowering with statins after acute coronary syndromes.
BACKGROUND Lipid-lowering therapy with statins reduces the risk of cardiovascular events, but the optimal level of low-density lipoprotein (LDL) cholesterol is unclear. METHODS We enrolled 4162 patients who had been hospitalized for an acute coronary syndrome within the preceding 10 days and compared 40 mg of pravastatin daily (standard therapy) with 80 mg of atorvastatin daily (intensive the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2008
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2007.11.075